Efficacy of gabapentin in migraine prophylaxis

Headache

Volumn 41, Issue 2, 2001, Pages 119-128

  Mathew, Ninan T ^a,i   Rapoport, Alan ^b   Saper, Joel ^c   Magnus, Leslie ^d   Klapper, Jack ^e   Ramadan, Nabih ^f   Stacey, Brett ^g   Tepper, Stewart ^h  

^a Houston (Tex) Headache Clinic   (United States)

^b New England Headache Center   (United States)

^c Michigan Head Pain and Neurological Institute   (United States)

^d PFIZER INC   (United States)

^e Colorado Neurology and Headache Center ^*  (United States)

^f UNIVERSITY OF CINCINNATI   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^h Polyclinic   (United States)

ⁱ Houston Headache Clinic   (United States)

Author keywords

Gabapentin; Migraine; Prophylaxis

Indexed keywords

GABAPENTIN; PLACEBO;

ADULT; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COVARIANCE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; STATISTICAL ANALYSIS; VERTIGO;

ACETIC ACIDS; ADOLESCENT; ADULT; AGED; AMINES; ANALGESICS; CYCLOHEXANECARBOXYLIC ACIDS; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS;

EID: 0035097928     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2001.111006119.x     Document Type: Article

References (3)

1. Ramadan NM, Schultz LL, Gilkey SJ. Migraine prophylactic drugs: proof of efficacy, utilization and cost. Cephalalgia. 1997;17:73-80.
2. Taylor CP, Vartanian MG, Andruszkiewicz R, Silverman RB. 3-alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agents. Epilepsy Res. 1992;11:103-110.
3. Petroff OA, Rothman DL, Behar KL, Lamoureux D, Mattson RH. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann Neurol. 1996;39:95-99.